Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.11 USD | +1.45% | +3.05% | +22.28% |
May. 08 | Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2022 | 4.81M | Sales 2023 | 2.13M | Capitalization | 13.57M |
---|---|---|---|---|---|
Net income 2022 | -113M | Net income 2023 | -62M | EV / Sales 2022 | -17.6 x |
Net cash position 2022 | 96.61M | Net cash position 2023 | 57.06M | EV / Sales 2023 | -20.4 x |
P/E ratio 2022 |
-0.11
x | P/E ratio 2023 |
-0.22
x | Employees | 99 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.69% |
Latest transcript on Talis Biomedical Corporation
1 day | +1.45% | ||
1 week | +3.05% | ||
Current month | +5.68% | ||
1 month | +1.22% | ||
3 months | +8.32% | ||
6 months | +27.23% | ||
Current year | +22.28% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director of Finance/CFO | 51 | 21-12-31 | |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 16-02-29 |
Randal Scott
BRD | Director/Board Member | 66 | 13-12-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 9.11 | +1.45% | 6 185 |
24-05-17 | 8.98 | -1.97% | 2,170 |
24-05-16 | 9.16 | +2.34% | 5,148 |
24-05-15 | 8.95 | +2.64% | 8,399 |
24-05-14 | 8.72 | -1.36% | 9,856 |
Delayed Quote Nasdaq, May 20, 2024 at 01:53 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+22.28% | 16.36M | |
+40.92% | 50.93B | |
-0.45% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.71% | 26.02B | |
-21.59% | 18.9B | |
+7.24% | 13.21B | |
+24.54% | 12.17B | |
+30.12% | 12.16B |
- Stock Market
- Equities
- TLIS Stock